JPH10147514A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH10147514A JPH10147514A JP8323492A JP32349296A JPH10147514A JP H10147514 A JPH10147514 A JP H10147514A JP 8323492 A JP8323492 A JP 8323492A JP 32349296 A JP32349296 A JP 32349296A JP H10147514 A JPH10147514 A JP H10147514A
- Authority
- JP
- Japan
- Prior art keywords
- decenoic acid
- acid
- skin
- hydroxy
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- QHBZHVUGQROELI-UHFFFAOYSA-N 10-hydroxydec-2-enoic acid Chemical class OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 claims abstract description 24
- KUPHXIFBKAORGY-UHFFFAOYSA-N 2-amino-3-iodo-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(N)=C1I KUPHXIFBKAORGY-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930091371 Fructose Natural products 0.000 claims abstract description 3
- 239000005715 Fructose Substances 0.000 claims abstract description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 3
- 239000008103 glucose Substances 0.000 claims abstract description 3
- 150000002772 monosaccharides Chemical group 0.000 claims abstract description 3
- 150000004043 trisaccharides Chemical group 0.000 claims abstract description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims abstract 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract 2
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 claims abstract 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract 2
- 125000000600 disaccharide group Chemical group 0.000 claims abstract 2
- 229930182830 galactose Natural products 0.000 claims abstract 2
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 claims abstract 2
- -1 laminariviose Chemical compound 0.000 claims description 30
- 229930182470 glycoside Natural products 0.000 claims description 12
- 150000002338 glycosides Chemical class 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 150000001720 carbohydrates Chemical group 0.000 claims description 2
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 claims 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims 1
- OKPQBUWBBBNTOV-UHFFFAOYSA-N Kojibiose Natural products COC1OC(O)C(OC2OC(OC)C(O)C(O)C2O)C(O)C1O OKPQBUWBBBNTOV-UHFFFAOYSA-N 0.000 claims 1
- VSRVRBXGIRFARR-CIYSLCTESA-N Neohesperidose Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 VSRVRBXGIRFARR-CIYSLCTESA-N 0.000 claims 1
- VSRVRBXGIRFARR-OUEGHFHCSA-N alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O VSRVRBXGIRFARR-OUEGHFHCSA-N 0.000 claims 1
- FBJQEBRMDXPWNX-CFCQXFMMSA-N beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](O)O2)O)O1 FBJQEBRMDXPWNX-CFCQXFMMSA-N 0.000 claims 1
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 claims 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims 1
- PZDOWFGHCNHPQD-OQPGPFOOSA-N kojibiose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-OQPGPFOOSA-N 0.000 claims 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims 1
- QIGJYVCQYDKYDW-NSYYTRPSSA-N nigerose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-NSYYTRPSSA-N 0.000 claims 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004761 scalp Anatomy 0.000 abstract description 7
- 229940109850 royal jelly Drugs 0.000 abstract description 6
- 230000037303 wrinkles Effects 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000000047 product Substances 0.000 description 23
- 230000003779 hair growth Effects 0.000 description 21
- 235000015961 tonic Nutrition 0.000 description 19
- 230000001256 tonic effect Effects 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 239000002884 skin cream Substances 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 239000008213 purified water Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 230000002500 effect on skin Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 4
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- QURCVMIEKCOAJU-HWKANZROSA-N Isoferulic acid Natural products COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229950004864 olamine Drugs 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- AQZLKGKBZLRIIU-UHFFFAOYSA-N 6-chloro-1,5-dimethylcyclohexa-2,4-dien-1-ol Chemical compound CC1=CC=CC(C)(O)C1Cl AQZLKGKBZLRIIU-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000219475 Bougainvillea Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- JQQBXPCJFAKSPG-SVYIMCMUSA-N Geraniin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]3OC(=O)C=4C=C(O)C(O)=C5O[C@@]6(O)C(=O)C=C([C@@H](C5=4)C6(O)O)C(=O)O[C@H]4[C@@H]3OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@H]4O2)=C1 JQQBXPCJFAKSPG-SVYIMCMUSA-N 0.000 description 1
- 229920000061 Geraniin Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- NJEMMCIKSMMBDM-UHFFFAOYSA-N bis(2-ethoxyethyl) hexanedioate Chemical compound CCOCCOC(=O)CCCCC(=O)OCCOCC NJEMMCIKSMMBDM-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- USAHNNPOSAWOSH-UHFFFAOYSA-N dec-8-en-1-ol Chemical compound CC=CCCCCCCCO USAHNNPOSAWOSH-UHFFFAOYSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical group 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- GJMUCSXZXBCQRZ-UHFFFAOYSA-N geraniin Natural products Oc1cc(cc(O)c1O)C(=O)OC2OC3COC(=O)c4cc(O)c(O)c(O)c4c5cc(C(=O)C67OC3C(O6)C2OC(=O)c8cc(O)c(O)c9OC%10(O)C(C(=CC(=O)C%10(O)O)C7=O)c89)c(O)c(O)c5O GJMUCSXZXBCQRZ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229940075065 polyvinyl acetate Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229940100996 sodium bisulfate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は化粧料に関し、詳し
くは皮膚や頭皮を賦活化し、肌荒れの改善,肌のつやの
改善,シワの伸展,タルミの収れんなどの美肌効果に優
れた皮膚化粧料や、発毛・育毛効果に優れた頭髪化粧料
を提供せんとするものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to cosmetics, and more particularly, to skin cosmetics which activate the skin and scalp and have excellent skin effects such as improvement of rough skin, improvement of skin luster, extension of wrinkles and convergence of tarmi. Another object of the present invention is to provide a hair cosmetic composition having excellent hair growth and hair growth effects.
【0002】[0002]
【従来の技術】従来から皮膚化粧料や頭髪化粧料には肌
荒れ防止、しわの改善または発毛・育毛などを目的とし
て各種の動植物エキスあるいは各種の化合物などが配合
されてきた。例えば動植物エキスとしては胎盤抽出物、
ロイヤルゼリー、ヨクイニン、オウゴン、ブクリョウ等
の抽出エキスなど、また化合物としてはビタミンC、ビ
タミンE、レチノール誘導体、ミノキシジルなどが挙げ
られる。2. Description of the Related Art Conventionally, skin cosmetics and hair cosmetics have been blended with various animal and plant extracts or various compounds for the purpose of preventing rough skin, improving wrinkles, or growing and growing hair. For example, a placenta extract as an animal or plant extract,
Extracts such as royal jelly, yokunin, gougon, and bougainvillea, and examples of compounds include vitamin C, vitamin E, retinol derivatives, minoxidil, and the like.
【0003】この中でもロイヤルゼリーは、安全性面に
優れ、古来から滋養強壮剤として用いられるだけでな
く、美肌を目的とした化粧料や発毛・育毛料における有
効成分としても重用されてきた。[0003] Among them, royal jelly is excellent in safety and has been used not only as a nourishing tonic since ancient times, but also as an active ingredient in cosmetics and hair growth / hair restoration for the purpose of beautiful skin.
【0004】[0004]
【発明の解決しようとする課題】ところが、ロイヤルゼ
リーは脂質、蛋白質ならびに糖類などの複雑な混合物で
ある為、水、エタノールまたは油に対する溶解性が極め
て低いこと、及び化粧品製造時に蛋白成分が熱変性を起
こす危険があることなどから、配合量や剤型面からの制
約が多く、なかなか実用的には使用し得ないものであっ
た。However, since royal jelly is a complex mixture of lipids, proteins and saccharides, it has a very low solubility in water, ethanol or oil, and the protein component is thermally denatured during the production of cosmetics. For this reason, there are many restrictions on the blending amount and the dosage form because of the danger of occurrence of phenomena, and it is difficult to use them practically.
【0005】そこで、本発明者らは上記ロイヤルゼリー
の抱える課題を克服するため、検討を加えた結果、ロイ
ヤルゼリーの有効成分が10−ヒドロキシ−2−デセン
酸であることを突き止め、これを特許出願した(特開昭
61−171413号公報、特開昭61−176510
号公報参照)。The inventors of the present invention have conducted studies to overcome the above-mentioned problems of royal jelly, and as a result, have found that the active ingredient of royal jelly is 10-hydroxy-2-decenoic acid. Application (JP-A-61-171413, JP-A-61-176510)
Reference).
【0006】しかしながら、10−ヒドロキシ−2−デ
セン酸は、上記特許出願した如く美白効果や発毛・育毛
効果に優れているのに加え、抗菌、血流量増加などの作
用があることも知られているが、一方、水相に対する溶
解性は極めて低く、化粧料の有効成分として自由に使用
するには未だ課題が残されていた。However, it is also known that 10-hydroxy-2-decenoic acid is not only excellent in whitening effect, hair growth and hair growth effect as described in the above patent application, but also has actions such as antibacterial and blood flow increase. However, on the other hand, the solubility in the aqueous phase is extremely low, and there is still a problem in freely using it as an active ingredient of cosmetics.
【0007】本発明は、斯かる実状に鑑みてなされたも
のであって、10−ヒドロキシ−2−デセン酸の使用上
での制約を改善し、且つ皮膚や頭皮を賦活化し、肌荒れ
の改善,肌のつやの改善,シワの伸展,タルミの収れん
などの美肌効果に優れた皮膚化粧料や、発毛・育毛効果
に優れた頭髪化粧料を提供することを課題とする。The present invention has been made in view of the above-mentioned circumstances, and has been made to improve the restrictions on the use of 10-hydroxy-2-decenoic acid, activate the skin and scalp, and improve the roughness of the skin. It is an object of the present invention to provide a skin cosmetic excellent in beautiful skin effect such as improvement of skin gloss, extension of wrinkles, convergence of tarumi, and a hair cosmetic excellent in hair growth and hair growth effects.
【0008】[0008]
【課題を解決するための手段】本発明者は、上記課題を
解決するため鋭意研究を行なった結果、10−ヒドロキ
シ−2−デセン酸の水酸基部分を配糖体化すると、水相
に対する溶解性が向上するばかりでなく、更には配糖体
化された10−ヒドロキシ−2−デセン酸は10−ヒド
ロキシ−2−デセン酸よりも優れた美肌効果、また発毛
・育毛効果を有していることを見出し、斯かる知見に基
づき本発明を完成させた。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems. As a result, when the hydroxyl group of 10-hydroxy-2-decenoic acid is converted into a glycoside, the solubility in the aqueous phase is reduced. In addition to improving glycerol, 10-hydroxy-2-decenoic acid that has been glycosidized has a more beautiful skin effect than 10-hydroxy-2-decenoic acid, and also has a hair growth and hair growth effect. The inventors have found that the present invention has been completed based on such findings.
【0009】すなわち、本発明は、下記一般式(I)で
表される10−ヒドロキシ−2−デセン酸の配糖体を好
適には化粧料全体に対して総量で0.001〜10重量
%含有することを特徴とする化粧料に関するものであ
る。That is, in the present invention, the total amount of the glycoside of 10-hydroxy-2-decenoic acid represented by the following general formula (I) is preferably 0.001 to 10% by weight based on the total amount of the cosmetic. The present invention relates to a cosmetic characterized by containing.
【0010】 R−OCH2(CH2)6CH=CHCOOH (I) (式中、Rは単糖類残基、二糖類残基又は三糖類残基を
表す。)R—OCH 2 (CH 2 ) 6 CH = CHCOOH (I) (wherein, R represents a monosaccharide residue, a disaccharide residue or a trisaccharide residue.)
【0011】以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
【0012】本発明に適用される10−ヒドロキシ−2
−デセン酸の配糖体は、上記一般式(I)に示される如
く10−ヒドロキシ−2−デセン酸の水酸基を配糖体化
したものであり、具体的には例えば10−グルコシル−
2−デセン酸、10−ガラクトシル−2−デセン酸、1
0−マンノシル−2−デセン酸、10−キシロシル−2
−デセン酸、10−フルクトシル−2−デセン酸、10
−マルトシル−2−デセン酸、10−イソマルトシル−
2−デセン酸、10−セロビオシル−2−デセン酸、1
0−ゲンチオビオシル−2−デセン酸、10−コージビ
オシル−2−デセン酸、10−ラミナリビオシル−2−
デセン酸、10−ニゲロシル−2−デセン酸、10−サ
ンブビオシル−2−デセン酸、10−ネオヘスペリドシ
ル−2−デセン酸、10−マルトトリオシル−2−デセ
ン酸、10−イソマルトトリオシル−2−デセン酸、1
0−セロトリオシル−2−デセン酸、10−ゲンチオト
リオシル−2−デセン酸などが挙げられるが、美肌効果
及び発毛・育毛効果の点からは10−グルコシル−2−
デセン酸、10−ガラクトシル−2−デセン酸、10−
マルトシル−2−デセン酸、10−セロビオシル−2−
デセン酸が好ましく、特に10−グルコシル−2−デセ
ン酸が好ましい。10-hydroxy-2 applied to the present invention
The glycoside of -decenoic acid is a glycoside of the hydroxyl group of 10-hydroxy-2-decenoic acid as shown in the general formula (I), and specifically, for example, 10-glucosyl-
2-decenoic acid, 10-galactosyl-2-decenoic acid, 1
0-mannosyl-2-decenoic acid, 10-xylosyl-2
-Decenoic acid, 10-fructosyl-2-decenoic acid, 10
-Maltosyl-2-decenoic acid, 10-isomaltosyl-
2-decenoic acid, 10-cellobiosyl-2-decenoic acid, 1
0-gentiobiosyl-2-decenoic acid, 10-cordibiosyl-2-decenoic acid, 10-laminaribiosyl-2-
Decenoic acid, 10-nigerosyl-2-decenoic acid, 10-sambubiosyl-2-decenoic acid, 10-neoshesperidosyl-2-decenoic acid, 10-maltotriosyl-2-decenoic acid, 10-isomaltotriosyl -2-decenoic acid, 1
Examples thereof include 0-serotriosyl-2-decenoic acid and 10-gentiotriosyl-2-decenoic acid, and 10-glucosyl-2-decenoic acid from the viewpoints of a beautiful skin effect and a hair growth and hair growth effect.
Decenoic acid, 10-galactosyl-2-decenoic acid, 10-
Maltosyl-2-decenoic acid, 10-cellobiosyl-2-
Decenoic acid is preferred, especially 10-glucosyl-2-decenoic acid.
【0013】前記一般式(I)の10−ヒドロキシ−2
−デセン酸の配糖体は、10−ヒドロキシ−2−デセン
酸とアセチル化糖からChiron,R.の方法(J.
Chem.Ecol.,8:709−713,198
2)に従って合成することができる。その際、10−ヒ
ドロキシ−2−デセン酸のカルボキシル基か水酸基、あ
るいはその両方の部位に糖残基の結合した物質が得られ
るが、カラム精製等によって目的物である10−ヒドロ
キシ−2−デセン酸の配糖体を分離することができる。
以下にその合成方法を、10−グルコシル−2−デセン
酸を例にとって説明する。The 10-hydroxy-2 of the general formula (I)
Glycosides of -decenoic acid are obtained from 10-hydroxy-2-decenoic acid and acetylated sugars in Chiron, R .; Method (J.
Chem. Ecol. , 8: 709-713, 198.
It can be synthesized according to 2). At this time, a substance in which a sugar residue is bonded to a carboxyl group or a hydroxyl group of 10-hydroxy-2-decenoic acid, or both of them can be obtained. The target substance, 10-hydroxy-2-decene, is obtained by column purification or the like. Acid glycosides can be separated.
Hereinafter, the synthesis method will be described using 10-glucosyl-2-decenoic acid as an example.
【0014】10−ヒドロキシ−2−デセン酸とテトラ
−O−アセチル−D−グルコピラノシルブロミドをジク
ロロメタン中で、テトラメチル尿素とシルバートリフレ
ートとの混合触媒下、氷冷しながら窒素気流中で2時間
反応させる。その後、ジクロロメタン層を蒸発乾固さ
せ、シリカゲルカラムクロマトグラフィーで反応物を分
画単離した後、ナトリウムメチラートを用いて脱アセチ
ル化することにより、10−グルコシル−2−デセン酸
を得た。[0014] 10-Hydroxy-2-decenoic acid and tetra-O-acetyl-D-glucopyranosyl bromide are mixed in dichloromethane under a mixed catalyst of tetramethylurea and silver triflate in a nitrogen stream while cooling with ice. And react for 2 hours. Thereafter, the dichloromethane layer was evaporated to dryness, the reaction product was fractionated and isolated by silica gel column chromatography, and then deacetylated using sodium methylate to obtain 10-glucosyl-2-decenoic acid.
【0015】その他の配糖体化合物も、相当するピラノ
シルブロミド誘導体を用いて上記方法に準じて製造する
ことができる。Other glycoside compounds can also be produced according to the above method using the corresponding pyranosyl bromide derivative.
【0016】次に、本発明の化粧料では10−ヒドロキ
シ−2−デセン酸の配糖体の含有量は、化粧料全体に対
して総量で好ましくは0.001〜10重量%、更に好
ましくは、0.005〜5重量%である。0.001重
量%より少ないと美肌効果や発毛・育毛効果が低下し、
また10重量%を越えた量を用いても効果の増強は見ら
れず不経済であるので上記範囲で含有することが好まし
い。Next, in the cosmetic of the present invention, the content of the glycoside of 10-hydroxy-2-decenoic acid is preferably 0.001 to 10% by weight, more preferably the total amount, based on the total amount of the cosmetic. , 0.005 to 5% by weight. If it is less than 0.001% by weight, the beautiful skin effect and the hair growth / hair growth effect are reduced,
Use of an amount exceeding 10% by weight does not increase the effect and is uneconomical.
【0017】また、本発明に係る10−ヒドロキシ−2
−デセン酸の配糖体を化粧料中に配合する場合、特に配
慮の必要はないが、好適には10−ヒドロキシ−2−デ
セン酸の配糖体を少量のエタノールに溶解した後、水相
あるいは油相成分と混合する方法が好ましい。The 10-hydroxy-2 according to the present invention
-When blending the glucoside of decenoic acid in the cosmetic, there is no particular consideration, but it is preferable to dissolve the glucoside of 10-hydroxy-2-decenoic acid in a small amount of ethanol and then add the aqueous phase to the aqueous phase. Alternatively, a method of mixing with an oil phase component is preferable.
【0018】本発明の化粧料中には、前述の有効成分の
他に、化粧品に一般に用いられる各種成分、即ち水性成
分、油性成分、粉末成分、界面活性剤(乳化剤)、保湿
剤、増粘剤、色剤、香料、抗酸化剤、pH調整剤、キレ
ート剤、防腐剤、あるいは紫外線防御剤、抗炎症剤、美
白剤等の成分を1種又は2種以上を配合することができ
る。In the cosmetic of the present invention, in addition to the aforementioned active ingredients, various components generally used in cosmetics, that is, aqueous components, oil components, powder components, surfactants (emulsifiers), humectants, thickeners One or more components such as agents, coloring agents, fragrances, antioxidants, pH adjusters, chelating agents, preservatives, or ultraviolet protective agents, anti-inflammatory agents, and whitening agents can be blended.
【0019】水性成分としては、例えば水(精製水)、
低級アルコール(エタノール、プロパノール、イソプロ
パノール)等が挙げられる。Examples of the aqueous component include water (purified water),
Lower alcohols (ethanol, propanol, isopropanol) and the like.
【0020】油性成分としては、例えば高級脂肪酸類
(ステアリン酸、パルミチン酸、ミリスチン酸、ラウリ
ン酸、およびそれらのエステル等)、高級アルコール類
(セタノール、ラノリンアルコール、ステアリルアルコ
ール、セトステアリルアルコール等)及びワックス類
(固形パラフィン、マイクロクリスタリンワックス、セ
レシンワックス、ポリエチレンワックス、蜜ロウ、木ロ
ウ、カルナウバロウ、キャンデリラロウ等)、天然又は
合成油状物質(スクワラン、流動パラフィン、ラノリン
またはその誘導体、オリーブ油、椿油、綿実油、オレイ
ルアルコール、ひまし油、ワセリン、アジピン酸ジエト
キシエチルエステル、シリコンオイル、弗素オイル等)
が挙げられる。Examples of the oily component include higher fatty acids (stearic acid, palmitic acid, myristic acid, lauric acid and esters thereof), higher alcohols (cetanol, lanolin alcohol, stearyl alcohol, cetostearyl alcohol, etc.) and the like. Waxes (solid paraffin, microcrystalline wax, ceresin wax, polyethylene wax, beeswax, wood wax, carnauba wax, candelilla wax, etc.), natural or synthetic oils (squalane, liquid paraffin, lanolin or derivatives thereof, olive oil, camellia oil, Cottonseed oil, oleyl alcohol, castor oil, petrolatum, diethoxyethyl adipate, silicone oil, fluorine oil, etc.)
Is mentioned.
【0021】粉末成分としては、例えばアルミニウム粉
末、酸化チタン粉末、酸化亜鉛粉末、酸化鉄粉末、アク
リル粉体、シリカビーズ、タルク、セリサイト等が挙げ
られる。Examples of the powder component include aluminum powder, titanium oxide powder, zinc oxide powder, iron oxide powder, acrylic powder, silica beads, talc, and sericite.
【0022】界面活性剤としては、例えばポリオキシエ
チレンモノオレエート、ポリオキシエチレンセチルエー
テル、ステアリン酸アルミニウム、オクチルドデカノー
ル、新油型モノステアリン酸グリセリン、モノステアリ
ン酸プロピレングリコール等が挙げられる。Examples of the surfactant include polyoxyethylene monooleate, polyoxyethylene cetyl ether, aluminum stearate, octyldodecanol, glycerin monostearate, propylene glycol monostearate and the like.
【0023】保湿剤としては、例えばグリセリン、プロ
ピレングリコール、1,3−ブチレングリコール、ジプ
ロピレングリコール、エチレングリコール、1,4−ブ
チレングリコール、ジグリセリン、トリグリセリン、ソ
ルビット及びその誘導体、ポリエチレングリコール等の
多価アルコール;グルコース、マルトース、マルチトー
ル、ショ糖、フルクトース、スレイトール、エリスリト
ール、ソルビット、澱粉分解糖、ヒアルロン酸、コンド
ロイチン硫酸、加水分解コラーゲン、カルボキシメチル
キチン等が挙げられる。Examples of the humectant include glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, ethylene glycol, 1,4-butylene glycol, diglycerin, triglycerin, sorbit and its derivatives, and polyethylene glycol. Polyhydric alcohols include glucose, maltose, maltitol, sucrose, fructose, threitol, erythritol, sorbitol, starch-degrading sugar, hyaluronic acid, chondroitin sulfate, hydrolyzed collagen, carboxymethyl chitin and the like.
【0024】増粘剤としては、例えばカルボキシビニル
ポリマー、CPゼリー、カルボキシメチルセルロース、
カラギーナン、アルギン酸ナトリウム、ポリ酢酸ビニル
エマルジョン、ポリビニルアルコール、ベントナイト、
ビーガム、合成ヘクトライト等が挙げられる。Examples of the thickener include carboxyvinyl polymer, CP jelly, carboxymethylcellulose,
Carrageenan, sodium alginate, polyvinyl acetate emulsion, polyvinyl alcohol, bentonite,
Vegum, synthetic hectorite and the like.
【0025】抗酸化剤としては、例えばジブチル化ヒド
ロキシトルエン(BHT)、ブチル化ヒドロキシアニソ
ール(BHA)、トコフェロ−ルピロ亜硫酸ナトリウ
ム、ソジウムビサルフェート、酢酸トコフェロール、ビ
タミンE、ローズマリーエキス等が挙げられる。Examples of the antioxidant include dibutylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), sodium tocopherol-pyrosulfite, sodium bisulfate, tocopherol acetate, vitamin E, rosemary extract and the like. .
【0026】pH調整剤としては、例えばクエン酸、乳
酸、酒石酸、燐酸等が挙げられる。キレート剤として
は、例えばEDTA(エチレンジアミンテトラ酢酸)、
チオグリコ−ル酸、チオ乳酸、チオグリセリン等が挙げ
られる。Examples of the pH adjuster include citric acid, lactic acid, tartaric acid, phosphoric acid and the like. Examples of the chelating agent include EDTA (ethylenediaminetetraacetic acid),
Thioglycolic acid, thiolactic acid, thioglycerin and the like.
【0027】防腐剤としては、例えばp−オキシ安息香
酸のメチル、エチル、プロピル、ブチルエステル(それ
ぞれメチルパラベン、エチルパラベン、プロピルパラベ
ン、ブチルパラベンと呼ばれている)、o−フェニルフ
ェノール、デヒドロ酢酸及びその塩、p−クレゾール、
m−クレゾール、o−クロル−m−キシレノール等が挙
げられる。As preservatives, for example, methyl, ethyl, propyl and butyl esters of p-oxybenzoic acid (referred to as methylparaben, ethylparaben, propylparaben and butylparaben, respectively), o-phenylphenol, dehydroacetic acid and Its salt, p-cresol,
m-cresol, o-chloro-m-xylenol and the like.
【0028】紫外線防御剤としては、例えばアスコルビ
ン酸又はその誘導体、イソフェルラ酸又はその塩、オキ
シベンゾン又はその誘導体、p−アミノ安息香酸又はそ
の誘導体、ウロカニン酸又はその誘導体、コウジ酸、ジ
ベンゾイルメタン又はその誘導体、p−メトキシ桂皮酸
又はその誘導体、微粒子酸化チタン、微粒子酸化亜鉛、
微粒子酸化鉄等が挙げられる。Examples of the ultraviolet protective agent include ascorbic acid or its derivative, isoferulic acid or its salt, oxybenzone or its derivative, p-aminobenzoic acid or its derivative, urocanic acid or its derivative, kojic acid, dibenzoylmethane or its derivative Derivatives, p-methoxycinnamic acid or derivatives thereof, fine particle titanium oxide, fine particle zinc oxide,
Fine particle iron oxide and the like.
【0029】抗炎症剤としては、例えばグリチルレチン
酸またはその誘導体、グリチルリチン酸またはその誘導
体、ビサボロール、ゲラニイン、マロニエ抽出物、アロ
エ抽出物等が挙げられる。Examples of the anti-inflammatory agent include glycyrrhetinic acid or a derivative thereof, glycyrrhizic acid or a derivative thereof, bisabolol, geraniin, malonier extract, and aloe extract.
【0030】美白剤としては、例えばパンテテイン−S
−スルフォン酸、イソフェルラ酸、アスコルビン酸及び
その燐酸マグネシウム塩、アルブチン、コウジ酸、リノ
ール酸、トラネキサム酸、エスクリン、ビタミンA酸、
レチノール等が挙げられる。As a whitening agent, for example, pantethein-S
-Sulfonic acid, isoferulic acid, ascorbic acid and its magnesium phosphate, arbutin, kojic acid, linoleic acid, tranexamic acid, esculin, vitamin A acid,
Retinol and the like.
【0031】これら各成分はそれぞれ単独で又は2種以
上混合して使用することができる。Each of these components can be used alone or in combination of two or more.
【0032】本発明の化粧料の剤型には特に制限はな
く、通常医薬部外品、化粧品などに用いられているも
の、例えば軟膏、クリ−ム、乳液、オイル、ロ−ショ
ン、パック、ヘアトニック、ヘアローション、ヘアクリ
ーム、ヘアトリートメント、シャンプー、リンス、ポマ
ード、浴用剤などの剤型が挙げられるが、経皮吸収性お
よび安定性の点から、クリーム、乳液、オイルなどが特
に好ましいといえる。The dosage form of the cosmetic of the present invention is not particularly limited, and those usually used for quasi-drugs, cosmetics, etc., for example, ointments, creams, emulsions, oils, lotions, packs, Examples include hair tonics, hair lotions, hair creams, hair treatments, shampoos, rinses, pomades, bath preparations, and the like, but from the viewpoint of transdermal absorption and stability, creams, emulsions, oils, and the like are particularly preferable. I can say.
【0033】[0033]
【発明の実施の形態】以下に、本発明で使用される一般
式(I)で示される10−ヒドロキシ−2−デセン酸の
配糖体の作用を、実験例に基づいて説明する。尚、後記
する実施例で使用した10−ヒドロキシ−2−デセン酸
の配糖体は前述の如くして得られたものである。BEST MODE FOR CARRYING OUT THE INVENTION The action of the glycoside of 10-hydroxy-2-decenoic acid represented by the general formula (I) used in the present invention will be described below based on experimental examples. In addition, the glycoside of 10-hydroxy-2-decenoic acid used in Examples described later was obtained as described above.
【0034】[ヒト美肌効果評価試験] (1)試料 本発明品1:後記実施例1のスキンクリーム 本発明品2:後記実施例2の乳液 比 較 品1:後記実施例1のスキンクリーム中の10−
グルコシル−2−デセン酸を10−ヒドロキシ−2−デ
セン酸に置き換えたスキンクリーム 比 較 品2:後記実施例1のスキンクリーム中の10−
グルコシル−2−デセン酸をビタミンCに置き換えたス
キンクリーム 比 較 品3:後記実施例2の乳液中の10−マルトシル
−2−デセン酸を10−ヒドロキシ−2−デセン酸に置
き換えた乳液 比 較 品4:後記実施例2の乳液中の10−マルトシル
−2−デセン酸をビタミンEに置き換えた乳液[Evaluation test for human skin effect] (1) Samples Invention product 1: Skin cream of Example 1 described below Invention product 2: Emulsion of Example 2 described later Comparative product 1: In skin cream of Example 1 described below 10-
Skin cream in which glucosyl-2-decenoic acid is replaced with 10-hydroxy-2-decenoic acid Comparative product 2: 10- in the skin cream of Example 1 described later
Skin cream in which glucosyl-2-decenoic acid was replaced by vitamin C Comparative product 3: Emulsion in which 10-maltosyl-2-decenoic acid in the emulsion of Example 2 described below was replaced by 10-hydroxy-2-decenoic acid Article 4: an emulsion obtained by replacing 10-maltosyl-2-decenoic acid in the emulsion of Example 2 with vitamin E
【0035】(2)試験方法 本邦30歳以上女子60名を、それぞれ20人ずつ無作
為に3群(A〜C群)に分けた。A群の手指には本発明
品1のスキンクリームを、B群の手指には比較品1のス
キンクリームを、C群の手指には比較品2のスキンクリ
ームをそれぞれ塗布した。一方、A群の顔面には本発明
品2の乳液を、B群の顔面には比較品3の乳液を、C群
の顔面には比較品4の乳液をそれぞれ塗布した。塗布は
一日2回12週間行い、12週間後の種々評価要素にお
ける改善状態について群間比較を行った。その結果を表
1(スキンクリーム)及び表2(乳液)に示す。(2) Test method Sixty girls aged 30 or older in Japan were randomly divided into three groups (groups A to C), each of which consisted of 20 women. The skin cream of the present invention product 1 was applied to the fingers of the group A, the skin cream of the comparative product 1 was applied to the fingers of the group B, and the skin cream of the comparative product 2 was applied to the fingers of the group C. On the other hand, the emulsion of the product 2 of the present invention was applied to the face of the group A, the emulsion of the comparative product 3 was applied to the face of the group B, and the emulsion of the comparative product 4 was applied to the face of the group C. The application was performed twice a day for 12 weeks, and an improvement in various evaluation factors after 12 weeks was compared between groups. The results are shown in Table 1 (skin cream) and Table 2 (emulsion).
【0036】[0036]
【表1】 [Table 1]
【0037】[0037]
【表2】 [Table 2]
【0038】表1の結果から明かな如く、本発明品のス
キンクリームは10−ヒドロキシ−2−デセン酸あるい
はビタミンC配合の比較品のスキンクリームに比し、評
価項目全般にわたってより良好な結果が得られ、特に小
じわ、つやの改善がより顕著であり、美肌効果に優れて
いることが実証された。同様に、表2の結果から明かな
如く、本発明品の乳液についても、10−ヒドロキシ−
2−デセン酸あるいはビタミンE配合の比較品の乳液に
比し、より顕著な改善がみられ美肌効果に優れているこ
とが実証された。As is evident from the results in Table 1, the skin cream of the present invention showed better results in all evaluation items than the comparative skin cream containing 10-hydroxy-2-decenoic acid or vitamin C. In particular, the improvement of fine wrinkles and gloss was more remarkable, and it was proved that the skin effect was excellent. Similarly, as is clear from the results in Table 2, the emulsion of the product of the present invention was also 10-hydroxy-
Compared to the emulsion of a comparative product containing 2-decenoic acid or vitamin E, a more remarkable improvement was observed, and it was proved that the skin beautiful effect was excellent.
【0039】[ヒト発毛・育毛効果評価試験] (1)試料 本発明品3 :後記実施例4のヘアトニック 本発明品4 :後記実施例5のヘアトニック 本発明品5 :後記実施例6のヘアトニック 比 較 品5 :後記実施例4のヘアトニック中の10−
グルコシル−2−デセン酸を10−ヒドロキシ−2−デ
セン酸に置き換えたヘアトニック コントロール:後記実施例4のヘアトニック中の10−
グルコシル−2−デセン酸を除き不足分を水で補ったヘ
アトニック[Human Hair Growth and Hair Growth Efficacy Evaluation Test] (1) Sample Product of the Invention 3: Hair tonic of Example 4 described below Product of the Invention 4: Hair tonic of Example 5 described below Product 5 of the invention: Example 6 described below Hair tonic comparative product 5: 10-
Hair tonic in which glucosyl-2-decenoic acid was replaced with 10-hydroxy-2-decenoic acid Control: 10-hydroxylated in the hair tonic of Example 4 described below.
Hair tonic in which the shortage is supplemented with water except for glucosyl-2-decenoic acid
【0040】(2)試験方法 本邦薄毛症、脱毛症を訴える50名の被験者をそれぞれ
10人ずつ5群(D〜H群)に分け、D群には本発明品
3のヘアトニックを、E群には本発明品4のヘアトニッ
クを、F群には本発明品5のヘアトニックを、G群には
比較品5のヘアトニックを、H群にはコントロールのヘ
アトニックを、それぞれ用いて24週間の長期連用試験
を実施した。適用方法は通常のトニック使用法と同様一
日2回、頭部にまんべんなく塗布する方法を用いた。ま
た、評価は12週間目と24週間目に行い、うぶ毛、硬
毛が増えてきたと感じた被験者がどの程度増えたかを計
測した。さらに塗布試験終了時に頭皮の状態の改善や、
ふけの発生の減少についても被験者に申告してもらっ
た。その結果を表3及び表4に示す。(2) Test Method Fifty subjects complaining of Japanese hair thinning and alopecia were divided into five groups (D to H groups) of 10 subjects each. The group using the hair tonic of the product 4 of the present invention, the group F using the hair tonic of the product 5 of the present invention, the group G using the hair tonic of the comparative product 5, and the group H using the hair tonic of the control. A 24-week long-term continuous test was conducted. The application method was a method of evenly applying the composition to the head twice a day as in the usual tonic usage. The evaluation was performed on the 12th week and the 24th week, and the number of test subjects who felt that the amount of downy hair and hard hair had increased was measured. Furthermore, at the end of the application test, the condition of the scalp was improved,
Subjects also reported a reduction in the occurrence of dandruff. The results are shown in Tables 3 and 4.
【0041】[0041]
【表3】 [Table 3]
【0042】[0042]
【表4】 [Table 4]
【0043】表3の結果から明かな如く、本発明品のヘ
アトニックは比較品のヘアトニックに比し、同一濃度で
うぶ毛あるいは硬毛を生じた人が増加しており、より発
毛効果を有することが立証された。更に表4の結果に示
される如く、全ての本発明品において、塗布試験終了時
の頭皮の状態が改善され、ふけ発生の減少を申告した人
が存在することから、本発明品のヘアトニックは育毛効
果も有することが明らかとなった。また、長期塗布試験
中にいずれの被験者にも頭皮状態の悪化、炎症性の反応
等の皮膚障害は全く観察されなかったことから安全性に
も問題のないことが確認された。As is evident from the results in Table 3, the hair tonic of the product of the present invention increased the number of people who had downy hair or hard hair at the same concentration as compared with the hair tonic of the comparative product, and showed a greater hair growth effect. It was proved to have Further, as shown in the results of Table 4, in all of the products of the present invention, the condition of the scalp at the end of the application test was improved, and there was a person who reported that the occurrence of dandruff was reduced. It was also revealed that the hair had a hair-growth effect. In addition, no skin damage such as deterioration of the scalp condition or inflammatory reaction was observed in any of the subjects during the long-term application test, and thus it was confirmed that there was no problem in safety.
【0044】[0044]
【実施例】以下に、本発明の実施例を説明する。尚、実
施例中の配合量は重量部である。Embodiments of the present invention will be described below. The amounts in the examples are parts by weight.
【0045】 実施例1.スキンクリーム (A)ミツロウ 3.0 セタノール 2.0 ステアリン酸 1.0 ワセリン 5.0 オリーブ油 4.0 スクワラン 5.0 グリセリンモノステアレート 1.0 POE(20)ソルビタンモノステアレート 3.0 10−グルコシル−2−デセン酸 0.5 (B)グリセリン 5.0 ポリエチレングリコール 3.0 防腐剤 0.3 精製水 67.1 (C)香料 0.1Embodiment 1 Skin cream (A) Beeswax 3.0 Cetanol 2.0 Stearic acid 1.0 Vaseline 5.0 Olive oil 4.0 Squalane 5.0 Glycerin monostearate 1.0 POE (20) Sorbitan monostearate 3.0 10- Glucosyl-2-decenoic acid 0.5 (B) Glycerin 5.0 Polyethylene glycol 3.0 Preservative 0.3 Purified water 67.1 (C) Fragrance 0.1
【0046】<調製方法>(A)の各成分を合わせ、7
0℃で加熱混合する。(B)の各成分を合わせ、70℃
で加熱混合し、これに(A)処方分を加え乳化し、40
℃に冷却する。更に(C)を加えて攪拌しながら常温ま
で冷却する。<Preparation method>
Heat and mix at 0 ° C. Combine each component of (B), 70 ° C
The mixture is heated and mixed with the mixture, and the formulation (A) is added thereto and emulsified.
Cool to ° C. Further, (C) is added, and the mixture is cooled to room temperature with stirring.
【0047】 実施例2.乳 液 (A)ワセリン 1.0 ミツロウ 1.0 スクワラン 5.0 ソルビタンモノステアレート 1.0 POE(20)モノステアレート 2.0 10−マルトシル−2−デセン酸 5.0 (B)カルボキシビニルポリマー 0.2 トリエタノールアミン 0.5 ポリエチレングリコール 4.0 防腐剤 0.3 精製水 79.9 (C)香 料 0.1Embodiment 2 Emulsion (A) Vaseline 1.0 Beeswax 1.0 Squalane 5.0 Sorbitan monostearate 1.0 POE (20) Monostearate 2.0 10-Maltosyl-2-decenoic acid 5.0 (B) Carboxyvinyl Polymer 0.2 Triethanolamine 0.5 Polyethylene glycol 4.0 Preservative 0.3 Purified water 79.9 (C) Fragrance 0.1
【0048】<調製方法>実施例1の方法と同様にして
調製した。<Preparation method> The preparation was carried out in the same manner as in Example 1.
【0049】 実施例3.化粧水 (A)POE(20)ソルビタンモノラウリン酸エステル 1.5 POE(20)ラウリルエステル 0.5 エタノール 10.0 γ−トコフェロール 0.02 10−ガラクトシル−2−デセン酸 0.05 (B)グリセリン 5.0 プロピレングリコール 4.0 クエン酸 0.15 クエン酸ナトリウム 0.1 精製水 78.68Embodiment 3 FIG. Lotion (A) POE (20) sorbitan monolaurate 1.5 POE (20) lauryl ester 0.5 ethanol 10.0 γ-tocopherol 0.02 10-galactosyl-2-decenoic acid 0.05 (B) glycerin 5.0 Propylene glycol 4.0 Citric acid 0.15 Sodium citrate 0.1 Purified water 78.68
【0050】<調製方法>(A)の各成分を合わせ、室
温下で溶解する。一方、(B)の各成分も室温下で溶解
し、これを(A)の成分に加えて可溶化する。<Preparation method> The components of (A) are combined and dissolved at room temperature. On the other hand, each component of (B) is also dissolved at room temperature, and is added to the component of (A) to be solubilized.
【0051】 実施例4.ヘアトニック (A)10−グルコシル−2−デセン酸 5.0 l−メントール 0.2 エタノール 32.5 (B)ポリオキシエチレン硬化ヒマシ油 0.5 精製水 61.7 (C)香料 0.1Embodiment 4 FIG. Hair tonic (A) 10-glucosyl-2-decenoic acid 5.0 1-menthol 0.2 ethanol 32.5 (B) Polyoxyethylene hydrogenated castor oil 0.5 Purified water 61.7 (C) Fragrance 0.1
【0052】<調製方法>(A)及び(B)の各成分を
それぞれ溶解し、混合した後、(C)を添加混合した。<Preparation Method> Each of the components (A) and (B) was dissolved and mixed, and then (C) was added and mixed.
【0053】 実施例5.ヘアトニック (A)10−グルコシル−2−デセン酸 0.05 l−メントール 0.2 エタノール 32.5 (B)ポリオキシエチレン硬化ヒマシ油 0.5 精製水 66.65 (C)香料 0.1Embodiment 5 FIG. Hair tonic (A) 10-glucosyl-2-decenoic acid 0.05 l-menthol 0.2 ethanol 32.5 (B) Polyoxyethylene hydrogenated castor oil 0.5 Purified water 66.65 (C) Fragrance 0.1
【0054】<調製方法>実施例4の方法と同様にして
調製した。<Preparation method> The preparation was carried out in the same manner as in Example 4.
【0055】 実施例6.ヘアトニック (A)10−グルコシル−2−デセン酸 0.005 l−メントール 0.2 エタノール 32.5 (B)ポリオキシエチレン硬化ヒマシ油 0.5 精製水 66.6995 (C)香料 0.1Embodiment 6 FIG. Hair tonic (A) 10-glucosyl-2-decenoic acid 0.005 1-menthol 0.2 ethanol 32.5 (B) Polyoxyethylene hydrogenated castor oil 0.5 Purified water 66.6995 (C) Fragrance 0.1
【0056】<調製方法>実施例4の方法と同様にして
調製した。<Preparation method> The preparation was carried out in the same manner as in Example 4.
【0057】 実施例7.ヘアトニック (A)メントール 0.2 ビタミンE 0.05 塩化カルプロニウム 0.1 エタノール 50.0 10−マルトシル−2−デセン酸 0.05 (B)プロピレングリコール 5.0 ビタミンB2 0.5 酵母抽出液(核酸含有) 0.5 グリチルリチンジカリウム 0.3 塩酸ジフェンヒドラミン 0.3 メチルパラベン 0.2 精製水 42.7 (C)香料 0.1Embodiment 7 Hair tonic (A) Menthol 0.2 Vitamin E 0.05 Carpronium chloride 0.1 Ethanol 50.0 10-Maltosyl-2-decenoic acid 0.05 (B) Propylene glycol 5.0 Vitamin B2 0.5 Yeast extract (Containing nucleic acid) 0.5 dipotassium glycyrrhizin 0.3 diphenhydramine hydrochloride 0.3 methyl paraben 0.2 purified water 42.7 (C) flavor 0.1
【0058】<調製方法>実施例4の方法と同様にして
調製した。<Preparation method> The preparation was carried out in the same manner as in Example 4.
【0059】 実施例8.ヘアトリートメント (A)流動パラフィン 2.0 メチルポリシロキサン(10cs) 2.0 セタノール 4.0 10−セロビオシル−2−デセン酸 5.0 (B)塩化ステアリルトリメチルアンモニウム 3.0 塩化ジステアリルジメチルアンモニウム 0.5 プロピレングリコール 5.0 ピロクトンオラミン 0.25 精製水 40.0 (C)加水分解コラーゲン 0.5 ヒアルロン酸 0.01 ウシ胎盤抽出エキス 0.5 塩化ジフェンヒドラミン 0.25 メチルパラベン 0.2 精製水 36.69 (D)香料 0.1Embodiment 8 FIG. Hair treatment (A) Liquid paraffin 2.0 Methyl polysiloxane (10 cs) 2.0 Cetanol 4.0 10-Cellobiosyl-2-decenoic acid 5.0 (B) Stearyltrimethylammonium chloride 3.0 Distearyldimethylammonium chloride 0 5.5 Propylene glycol 5.0 Pyrocton olamine 0.25 Purified water 40.0 (C) Hydrolyzed collagen 0.5 Hyaluronic acid 0.01 Bovine placenta extract 0.5 Diphenhydramine chloride 0.25 Methyl paraben 0.2 Purification Water 36.69 (D) Fragrance 0.1
【0060】<調製方法>(A)および(B)をそれぞ
れ80℃に加温した後、両者を混合して乳化し、40℃
付近まで冷却し、その後(C)及び(D)を添加混合し
た。<Preparation method> After each of (A) and (B) was heated to 80 ° C, the two were mixed and emulsified.
After cooling to the vicinity, (C) and (D) were added and mixed.
【0061】 実施例9.ヘアシャンプー (A)ラウリル硫酸トリエタノールアミン 10.0 ラウリル硫酸ナトリウム 5.0 ヤシ油ジエタノールアミド 2.0 プロピレングリコール 5.0 ピロクトンオラミン 0.25 ニコチン酸ベンジル 0.1 10−ガラクトシル−2−デセン酸 5.0 (B)トリクロロカルバニリド 0.25 精製水 72.3 (C)香 料 0.1Embodiment 9 Hair Shampoo (A) Triethanolamine Lauryl Sulfate 10.0 Sodium Lauryl Sulfate 5.0 Coconut Oil Diethanolamide 2.0 Propylene Glycol 5.0 Pyroctone Olamine 0.25 Benzyl Nicotinate 0.1 10-Galactosyl-2- Decenoic acid 5.0 (B) Trichlorocarbanilide 0.25 Purified water 72.3 (C) Fragrance 0.1
【0062】<調製方法>(A)を80℃にて混合し、
その後40℃付近まで冷却して(B)及び(C)を添加
混合した。<Preparation Method> (A) was mixed at 80 ° C.
Thereafter, the mixture was cooled to around 40 ° C., and (B) and (C) were added and mixed.
【0063】上記実施例7〜9で得られた本発明の化粧
料について実施例4〜6と同様に、または準ずる方法で
発毛・育毛効果を調べたところ、いずれも優れた効果を
示した。また、頭皮の状態の悪化、炎症性の反応等の皮
膚障害は全く観察されなかった。The hair growth and hair growth effects of the cosmetics of the present invention obtained in Examples 7 to 9 were examined in the same manner as in Examples 4 to 6 or by a method similar thereto, and all of them showed excellent effects. . In addition, no skin disorders such as deterioration of the scalp condition and inflammatory reaction were observed at all.
【0064】[0064]
【発明の効果】本発明によれば、従来から知られている
化粧料に比べて、小じわ、タルミ、つや不足、肌あれ等
の皮膚状態を改善する効果だけでなく、発毛・育毛効果
にも優れている上、皮膚に対する弊害もなく安全に使用
することができる。According to the present invention, as compared with the conventionally known cosmetics, not only the effect of improving the skin condition such as fine wrinkles, tarmi, lack of luster, and rough skin, but also the effect of hair growth and hair growth is achieved. And it can be used safely without any adverse effects on the skin.
Claims (3)
ロキシ−2−デセン酸の配糖体を含有することをを特徴
とする化粧料。 R−OCH2(CH2)6CH=CHCOOH (I) (式中、Rは単糖類残基、二糖類残基又は三糖類残基を
表す。)1. A cosmetic comprising a glycoside of 10-hydroxy-2-decenoic acid represented by the following general formula (I). R-OCH 2 (CH 2) 6 CH = CHCOOH (I) ( wherein, R represents a monosaccharide, disaccharide residue or trisaccharide residue.)
基が、グルコース、ガラクトース、マンノース、キシロ
ース、フルクトース、マルトース、イソマルトース、セ
ロビオース、ゲンチオビオース、コージビオース、ラミ
ナリビオース、ニゲロース、サンブビオース、ネオヘス
ペリドース、マルトトリオース、イソマルトトリオー
ス、セロトリオース及びゲンチオトリオースから選ばれ
る1種であることを特徴とする請求項1記載の化粧料。2. The method according to claim 1, wherein the saccharide residue represented by R in the general formula (I) is glucose, galactose, mannose, xylose, fructose, maltose, isomaltose, cellobiose, gentiobiose, kojibiose, laminariviose, nigerose, sambuobiose. 2. The cosmetic according to claim 1, wherein the cosmetic is one selected from the group consisting of, neohesperidose, maltotriose, isomalttriose, cellotriose and gentiotriose.
体の含有量が化粧料全体に対して総量で0.001〜1
0重量%である請求項1又は2の何れかに記載の化粧
料。3. The total content of the glycoside of 10-hydroxy-2-decenoic acid is 0.001 to 1 with respect to the total amount of the cosmetic.
The cosmetic according to claim 1, which is 0% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8323492A JPH10147514A (en) | 1996-11-19 | 1996-11-19 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8323492A JPH10147514A (en) | 1996-11-19 | 1996-11-19 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10147514A true JPH10147514A (en) | 1998-06-02 |
Family
ID=18155298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8323492A Pending JPH10147514A (en) | 1996-11-19 | 1996-11-19 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10147514A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783517A1 (en) * | 1998-09-22 | 2000-03-24 | Oreal | NOVEL DERIVATIVES OF 10-HYROXY-2-DECENOIC ACID AND USE IN A COMPOSITION FOR PROMOTING SKIN DESQUACATION, AND COMPOSITION COMPRISING SAME |
WO2000016739A1 (en) * | 1998-09-22 | 2000-03-30 | L'oreal | Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
WO2005034938A1 (en) * | 2003-10-07 | 2005-04-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Collagen productin enhancer and production process and use thereof |
US8158811B2 (en) | 2005-10-21 | 2012-04-17 | Pierre Fabre Dermo-Cosmetique | Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
CN117338613A (en) * | 2023-10-27 | 2024-01-05 | 山东福瑞达生物股份有限公司 | Composition for improving solubility of 10-hydroxy-2-decenoic acid in water, and preparation method and application thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61171413A (en) * | 1985-01-17 | 1986-08-02 | Pola Chem Ind Inc | Hair tonic |
JPS61176510A (en) * | 1985-01-31 | 1986-08-08 | Pola Chem Ind Inc | Skin-beautifying cosmetic |
JPH0390016A (en) * | 1989-08-31 | 1991-04-16 | Lion Corp | Composition for oral cavity |
JPH03115292A (en) * | 1989-09-28 | 1991-05-16 | Hayashibara Biochem Lab Inc | 4g-alpha-d-glucopyranosylrutin, production and use thereof |
JPH03255013A (en) * | 1990-03-01 | 1991-11-13 | San Ei Chem Ind Ltd | Cosmetic |
JPH04261115A (en) * | 1990-12-31 | 1992-09-17 | Shiseido Co Ltd | External agent for skin |
JPH05201846A (en) * | 1992-01-30 | 1993-08-10 | Pola Chem Ind Inc | External agent for skin |
JPH05213730A (en) * | 1992-02-04 | 1993-08-24 | Sansho Seiyaku Co Ltd | Tyrosinase activity-depressant |
JPH06256137A (en) * | 1993-03-01 | 1994-09-13 | Chugai Pharmaceut Co Ltd | Beautifying dermatic external preparation |
-
1996
- 1996-11-19 JP JP8323492A patent/JPH10147514A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61171413A (en) * | 1985-01-17 | 1986-08-02 | Pola Chem Ind Inc | Hair tonic |
JPS61176510A (en) * | 1985-01-31 | 1986-08-08 | Pola Chem Ind Inc | Skin-beautifying cosmetic |
JPH0390016A (en) * | 1989-08-31 | 1991-04-16 | Lion Corp | Composition for oral cavity |
JPH03115292A (en) * | 1989-09-28 | 1991-05-16 | Hayashibara Biochem Lab Inc | 4g-alpha-d-glucopyranosylrutin, production and use thereof |
JPH03255013A (en) * | 1990-03-01 | 1991-11-13 | San Ei Chem Ind Ltd | Cosmetic |
JPH04261115A (en) * | 1990-12-31 | 1992-09-17 | Shiseido Co Ltd | External agent for skin |
JPH05201846A (en) * | 1992-01-30 | 1993-08-10 | Pola Chem Ind Inc | External agent for skin |
JPH05213730A (en) * | 1992-02-04 | 1993-08-24 | Sansho Seiyaku Co Ltd | Tyrosinase activity-depressant |
JPH06256137A (en) * | 1993-03-01 | 1994-09-13 | Chugai Pharmaceut Co Ltd | Beautifying dermatic external preparation |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783517A1 (en) * | 1998-09-22 | 2000-03-24 | Oreal | NOVEL DERIVATIVES OF 10-HYROXY-2-DECENOIC ACID AND USE IN A COMPOSITION FOR PROMOTING SKIN DESQUACATION, AND COMPOSITION COMPRISING SAME |
EP0989111A1 (en) * | 1998-09-22 | 2000-03-29 | L'oreal | Derivatives of 10-hydroxy-2-decenoic acid and use in a composition favorable in the desquamation of the skin and composition containing the same |
WO2000016739A1 (en) * | 1998-09-22 | 2000-03-30 | L'oreal | Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
JP2002526433A (en) * | 1998-09-22 | 2002-08-20 | ロレアル | Use of at least one 10-hydroxy-2-decenoic acid derivative in a composition for promoting skin desquamation |
US6514507B2 (en) | 1998-09-22 | 2003-02-04 | Societe L'oreal S.A. | Hydroxydecenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging |
WO2005034938A1 (en) * | 2003-10-07 | 2005-04-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Collagen productin enhancer and production process and use thereof |
JP5050350B2 (en) * | 2003-10-07 | 2012-10-17 | 株式会社林原 | Collagen production enhancer, its production method and use |
US8158811B2 (en) | 2005-10-21 | 2012-04-17 | Pierre Fabre Dermo-Cosmetique | Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
CN117338613A (en) * | 2023-10-27 | 2024-01-05 | 山东福瑞达生物股份有限公司 | Composition for improving solubility of 10-hydroxy-2-decenoic acid in water, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100929264B1 (en) | External skin preparation | |
EP0440058B1 (en) | Cosmetic composition | |
JPH10279466A (en) | Preparation for external use | |
JP4080946B2 (en) | Skin preparation | |
JP3061295B2 (en) | Cosmetics | |
JPH10147514A (en) | Cosmetic | |
JP4828077B2 (en) | Topical skin preparation | |
JP3763810B2 (en) | Topical skin preparation | |
JP4076477B2 (en) | Skin preparation | |
JP2002080327A (en) | Hair grower | |
JP2004315442A (en) | Gray hair-preventing/improving agent | |
JPH08133950A (en) | Skin preparation for external use | |
JPH11236319A (en) | Composition for scalp and hair | |
JP3044690B2 (en) | Cosmetics | |
JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JP3542700B2 (en) | Head composition | |
JP2731226B2 (en) | External preparation for skin | |
JP2002363025A (en) | Skin care preparation and method for producing the same | |
JP2001081022A (en) | Skin cosmetic and black rings-improving agent | |
JP2780805B2 (en) | New skin external preparation composition | |
JPH11180833A (en) | Composition for scalp and hair | |
JPS60116616A (en) | Cosmetic | |
JPH11180832A (en) | Composition for scalp and hair | |
JP2000063255A (en) | Preparation for external use for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050121 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050525 |